title: Therapeutic effect of maprotiline and chlorimipramine: controlled study.
abstract: A study was done on 40 outpatients suffering from major affective disorders (uni- and bipolar). Chlorimipramine or maprotiline was administered alternatively (means = 116.25 and 116.75 mg/day, respectively). The therapeutic effect of both antidepressive drugs is very similar, but maprotiline improves the gastrointestinal somatic symptoms faster and seems to be more effective in bipolar patients. It also produces less side effects than chlorimipramine.
authors.affiliation: Department of Psychiatry, Hospital Clinico San Carlos, Madrid, Spain.
authors.forename: M L
authors.initials: ML
authors.lastname: Montejo-Iglesias
authors.forename: J A
authors.initials: JA
authors.lastname: Ramos-Brieva
mesh_terms: D000328:Adult; D000873:Anthracenes / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D002986:Clinical Trials as Topic; D002997:Clomipramine / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D008297:Male; D008376:Maprotiline / Q000627:therapeutic use*; D008875:Middle Aged; D011581:Psychological Tests
chemical_list: D000873:Anthracenes; D008376:Maprotiline; D002997:Clomipramine